# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-13-083839
Filing Date
2013-11-13
Accepted
2013-11-13 06:00:48
Documents
21
Period of Report
2013-11-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a13-23869_28k.htm | 8-K | 28096
2 | EX-99.1 | a13-23869_2ex99d1.htm | EX-99.1 | 27045
3 | EX-99.2 | a13-23869_2ex99d2.htm | EX-99.2 | 215179
4 | GRAPHIC | g238692mmi001.gif | GRAPHIC | 95577
5 | GRAPHIC | g238692mmi002.gif | GRAPHIC | 103818
6 | GRAPHIC | g238692mmi003.gif | GRAPHIC | 108133
7 | GRAPHIC | g238692mmi004.gif | GRAPHIC | 88561
8 | GRAPHIC | g238692mmi005.gif | GRAPHIC | 71741
9 | GRAPHIC | g238692mmi006.gif | GRAPHIC | 92895
10 | GRAPHIC | g238692mmi007.gif | GRAPHIC | 74627
11 | GRAPHIC | g238692mmi008.gif | GRAPHIC | 73063
12 | GRAPHIC | g238692mmi009.gif | GRAPHIC | 63216
13 | GRAPHIC | g238692mmi010.gif | GRAPHIC | 68254
14 | GRAPHIC | g238692mmi011.gif | GRAPHIC | 82976
15 | GRAPHIC | g238692mmi012.gif | GRAPHIC | 86779
16 | GRAPHIC | g238692mmi013.gif | GRAPHIC | 65017
17 | GRAPHIC | g238692mmi014.gif | GRAPHIC | 80098
18 | GRAPHIC | g238692mmi015.gif | GRAPHIC | 43767
19 | GRAPHIC | g238692mpi001.jpg | GRAPHIC | 38516
20 | GRAPHIC | g238692mpi002.jpg | GRAPHIC | 34644
21 | GRAPHIC | g238692mpi003.jpg | GRAPHIC | 3979
| Complete submission text file | 0001104659-13-083839.txt |  | 2031753

Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 131212365
SIC: 2834 Pharmaceutical Preparations